Search details
1.
Underweight and obesity are related to higher mortality in patients undergoing coronary angiography: The KARDIO invasive cardiology register study.
Catheter Cardiovasc Interv
; 100(7): 1242-1251, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36378689
2.
Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study.
Cardiology
; 137(4): 225-230, 2017.
Article
in English
| MEDLINE | ID: mdl-28467998
3.
Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome.
Scand Cardiovasc J
; 51(5): 248-254, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28666394
4.
Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.
Acta Radiol
; 58(9): 1077-1084, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28273737
5.
4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
Scand Cardiovasc J
; 50(4): 218-23, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27102382
6.
Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome HATTRICK-OCT trial.
Circ J
; 79(2): 360-7, 2015.
Article
in English
| MEDLINE | ID: mdl-25502167
7.
Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes.
Rev Esp Cardiol (Engl Ed)
; 76(3): 150-156, 2023 Mar.
Article
in English, Spanish
| MEDLINE | ID: mdl-35752571
8.
Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.
JAMA Cardiol
; 8(7): 703-708, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-37203243
9.
Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.
JACC Cardiovasc Interv
; 13(14): 1697-1705, 2020 07 27.
Article
in English
| MEDLINE | ID: mdl-32703593
10.
Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.
Eur J Intern Med
; 37: 43-48, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27499178
11.
Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial.
Angiology
; 68(6): 513-518, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-27543565
12.
Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.
Int J Cardiol
; 227: 194-200, 2017 Jan 15.
Article
in English
| MEDLINE | ID: mdl-27839810
13.
Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.
Ann Med
; 48(5): 376-83, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27238465
14.
Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
Int J Cardiovasc Imaging
; 32(7): 1031-9, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27076220
15.
Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome.
J Cardiovasc Med (Hagerstown)
; 16(3): 197-203, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25003998
16.
Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation.
Eur Heart J Cardiovasc Imaging
; 15(9): 1029-34, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24755162
17.
Pooled analysis of two randomized trials comparing titanium-nitride-oxide-coated stent versus drug-eluting stent in STEMI.
Rev Esp Cardiol (Engl Ed)
; 67(7): 531-7, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24952392
18.
Estudio comparativo de la cobertura neointimal entre los stents con recubrimiento de titanio-óxido nítrico y los liberadores de everolimus en el sindrome coronario agudo / Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes
Rev. esp. cardiol. (Ed. impr.)
; 76(3): 150-156, mar, 2023. ilus, tab
Article
in Spanish
| IBECS (Spain) | ID: ibc-216564
19.
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
Int J Cardiol
; 168(2): 1214-9, 2013 Sep 30.
Article
in English
| MEDLINE | ID: mdl-23218575
20.
Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.
J Invasive Cardiol
; 24(3): 104-8, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22388300